Skin Grafting Device Market Size & Growth Forecast 2027–2036, By Segments (Device Type, Application, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Skin Grafting Device Market size was assessed at USD 157.3 million in 2026 and is poised to grow at a 5.32% CAGR between 2027 and 2036, attaining USD 264.14 million by 2036. The industry revenue for 2027 is estimated at USD 164.35 million.
Get more details on this report
Request Free Sample ReportSkin Grafting Device Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 52.31% market share in 2026, supported by advanced surgical infrastructure, broad use of specialized grafting devices, and consistent demand from burn, trauma, and chronic wound procedures.
- Asia Pacific is projected to grow at a 6.44% CAGR as expanding hospital capacity, improved reconstructive care access, and rising surgical volumes accelerate adoption of advanced grafting devices.
Segment Momentum
- Dermatomes lead with 77.9% share due to their essential role in consistent graft harvesting and procedural control in burn and reconstructive surgeries, making them central to routine clinical workflows.
- Chronic Wound Care is the fastest-growing segment as demand rises for more effective long-term wound closure solutions, expanding grafting device use beyond acute burn treatment into persistent wound management pathways.
Market Expansion Drivers
- Rising incidence of severe burn injuries increasing demand for advanced skin grafting procedures.
- Government reimbursement support improving patient access to sophisticated wound treatment technologies.
- Advancements in regenerative medicine and bioengineered skin grafts enhancing reconstructive treatment outcomes.
Leading Market Participants
- Prominent companies in the skin grafting device market include Zimmer Biomet Holdings, Inc. (United States), Stryker Corporation (United States), B. Braun SE (Germany), Integra LifeSciences Holdings Corporation (United States), Mölnlycke Health Care AB (Sweden), De Soutter Medical Ltd. (United Kingdom), Exsurco Medical, Inc. (United States), NOUVAG AG (Switzerland), Aygün Surgical Instruments Co., Inc. (Turkey), Rudolf Storz GmbH (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 157.3 million
- 2027 Estimated Market Size: USD 164.35 million.
- Projected Market Size: USD 264.14 million by 2036
- Growth Forecast: 5.32% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Dermatomes (Device Type) | Burn Care (Application) | Hospitals (End-use)
- Emerging Opportunity Segment: Meshers (Device Type) | Chronic Wound Care (Application) | Ambulatory Surgical Centers (End-use)
Market Growth Drivers and Industry Trends
Rising incidence of severe burn injuries increasing demand for advanced skin grafting procedures
The skin grafting device market is gaining momentum from the need to treat patients with extensive burns that involve significant tissue damage and require surgical wound coverage. Severe burn injuries can compromise the body's natural protective barrier, making timely reconstruction important for reducing complications and supporting tissue healing. Advanced grafting devices assist clinicians in harvesting, preparing, expanding, and applying skin tissue with greater procedural control, which is particularly relevant when donor skin availability is limited. Growing clinical emphasis on effective wound closure and reconstructive care is increasing the use of specialized technologies in burn treatment settings.
Government reimbursement support improving patient access to sophisticated wound treatment technologies
Government reimbursement support is contributing to the skin grafting device market by improving the affordability and accessibility of reconstructive procedures for patients requiring complex wound management. Coverage for medically necessary burn treatment, surgical reconstruction, and related wound-care services can reduce financial barriers associated with advanced procedures and encourage healthcare providers to consider sophisticated treatment technologies. More predictable reimbursement mechanisms can also support investment in specialized equipment by hospitals and surgical centers seeking to provide comprehensive wound treatment. As healthcare systems place greater emphasis on accessible and clinically appropriate care, reimbursement policies can influence the adoption of advanced grafting technologies in eligible treatment settings.
Advancements in regenerative medicine and bioengineered skin grafts enhancing reconstructive treatment outcomes
Advancements in regenerative medicine are reshaping the skin grafting device market as clinicians gain access to bioengineered tissues and technologies designed to support more sophisticated reconstruction of damaged skin. Developments in tissue engineering, cell-based approaches, and engineered skin substitutes are expanding treatment options for patients whose wounds are too extensive for conventional grafting alone or who have limited donor tissue. These innovations also increase the need for specialized devices capable of preparing, handling, and applying graft materials with appropriate precision during surgical procedures. Continued progress in regenerative approaches is strengthening the role of advanced grafting technologies in reconstructive treatment pathways.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising incidence of severe burn injuries increasing demand for advanced skin grafting procedures | 2.10% | High | North America, Asia Pacific | High | Near Term |
| Government reimbursement support improving patient access to sophisticated wound treatment technologies | 1.80% | High | Europe, North America | High | Mid Term |
| Advancements in regenerative medicine and bioengineered skin grafts enhancing reconstructive treatment outcomes | 1.50% | High | North America, Europe | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the skin grafting device market, North America accounted for a 52.31% share in 2026, reflecting its advanced healthcare infrastructure, established reconstructive and wound-care capabilities, and strong adoption of specialized medical technologies. Demand is supported by the availability of sophisticated surgical facilities and increasing emphasis on effective tissue repair and patient recovery. Continued investment in advanced surgical techniques and growing clinical focus on improving grafting outcomes further reinforce the region’s market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, supported by expanding healthcare infrastructure, improving access to specialized surgical care, and rising adoption of advanced medical devices. Increasing healthcare investment is enabling more facilities to introduce modern reconstructive and wound-management technologies, while greater clinical awareness is supporting wider use of specialized grafting solutions. Growth in surgical care capacity and improvements in medical technology accessibility are creating favorable conditions for market expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Surgical Precision FocusGermany emphasizes skin grafting devices that deliver consistent graft quality and procedural precision in reconstructive and trauma surgery. Hospitals are investing in technologies that streamline surgical workflows while supporting specialized wound care practices.
France 🇫🇷
Specialized Hospital AdoptionFrance is expanding the use of skin grafting devices in specialized hospitals managing burns and complex wounds. The market values solutions that simplify surgical handling and contribute to standardized treatment protocols across clinical settings.
Italy 🇮🇹
Clinical Workflow EfficiencyItaly integrates skin grafting devices into reconstructive surgery and wound management programs to improve procedural consistency. Medical facilities prioritize user-friendly equipment that enhances surgical efficiency while supporting diverse patient care requirements.
Japan 🇯🇵
Minimally Invasive TechniquesJapan is advancing the use of skin grafting devices that enhance precision while minimizing tissue trauma. Clinical demand favors compact, reliable systems that integrate with modern surgical practices and improve efficiency in reconstructive procedures.
South Korea 🇰🇷
Reconstructive Care InnovationSouth Korea utilizes skin grafting devices across reconstructive, cosmetic, and burn treatment settings. Healthcare providers seek technologies that improve graft consistency, shorten procedure times, and support high-quality patient care.
United States 🇺🇸
Advanced Wound CareThe U.S. skin grafting device market is supported by increasing adoption of advanced wound management and reconstructive procedures. Healthcare providers prioritize devices that improve procedural efficiency, reduce operating time, and support better clinical outcomes in burn and chronic wound treatment.
Segment Leadership and Growth Trends
Skin Grafting Device Market Share (%), by Device Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportDevice Type Segment Analysis: Dermatomes (Largest Segment) vs Meshers (Fastest-Growing Segment)
Dermatomes led the skin grafting device market with a 77.9% share in 2026, reflecting their essential role in harvesting skin grafts for reconstructive procedures. These devices enable clinicians to obtain controlled layers of skin from donor sites, making them fundamental to procedures involving burns, traumatic injuries, and other conditions requiring tissue coverage. Their established clinical role and importance in achieving consistent graft preparation support widespread utilization across surgical settings. Continued demand for reconstructive care and effective wound coverage further reinforces the dominant position of dermatomes.
Meshers are the fastest-growing device type as clinicians increasingly seek efficient approaches for expanding harvested skin grafts and improving coverage of larger wound areas. These devices allow graft material to be expanded while maintaining its ability to cover irregular or extensive wounds, making them particularly useful in reconstructive procedures. Growing demand for efficient tissue utilization and advances in surgical wound management are supporting their adoption. Their contribution to improving graft coverage and procedural flexibility is expected to strengthen their role within skin grafting procedures.
Application Segment Analysis: Burn Care (Largest Segment) vs Chronic Wound Care (Fastest-Growing Segment)
Burn care accounted for the largest share of the skin grafting device market, reaching 47.51% in 2026, because extensive burn injuries frequently require surgical intervention and reliable skin replacement techniques. Skin grafting plays a critical role in restoring damaged tissue, supporting wound closure, and facilitating recovery following significant burns. The complexity of burn wounds creates sustained demand for devices that enable precise graft harvesting and preparation. Greater emphasis on specialized burn management and reconstructive treatment continues to support the strong position of this application segment.
Chronic wound care is the fastest-growing application as the increasing burden of persistent wounds creates greater demand for advanced tissue-repair approaches. Wounds associated with conditions such as impaired circulation and prolonged tissue damage often require sustained clinical management and may benefit from grafting when conventional healing approaches are insufficient. Growing emphasis on comprehensive wound management and improved reconstructive techniques is encouraging greater use of skin grafting devices in these cases. The expansion of specialized wound-care services and advances in surgical treatment are further supporting adoption across chronic wound applications.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Device Type | Dermatomes, Meshers, Accessories | Dermatomes | Meshers |
| Application | Burn Care, Chronic Wound Care, Reconstructive Surgery | Burn Care | Chronic Wound Care |
| End-use | Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Dermatology Clinics | Hospitals | Ambulatory Surgical Centers |
Competitive Landscape and Market Positioning
Prominent players in the skin grafting device market:
1. Zimmer Biomet Holdings Inc. (United States)
2. Stryker Corporation (United States)
3. B. Braun SE (Germany)
4. Integra LifeSciences Holdings Corporation (United States)
5. Mölnlycke Health Care AB (Sweden)
6. De Soutter Medical Ltd. (United Kingdom)
7. Exsurco Medical Inc. (United States)
8. NOUVAG AG (Switzerland)
9. Aygün Surgical Instruments Co. Inc. (Turkey)
10. Rudolf Storz GmbH (Germany)
The skin grafting device market is witnessing innovation driven by demand for minimally invasive wound treatment solutions and advanced tissue regeneration technologies. Manufacturers are focusing on improving graft precision, healing efficiency, and surgical ease through the use of automated and portable devices. Rising incidence of burn injuries and chronic wounds is also encouraging ongoing product development across the market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zimmer Biomet Holdings Inc. (United States) | |||||||
| Stryker Corporation (United States) | |||||||
| B. Braun SE (Germany) | |||||||
| Integra LifeSciences Holdings Corporation (United States) | |||||||
| Mölnlycke Health Care AB (Sweden) | |||||||
| De Soutter Medical Ltd. (United Kingdom) | |||||||
| Exsurco Medical Inc. (United States) | |||||||
| NOUVAG AG (Switzerland) | |||||||
| Aygün Surgical Instruments Co. Inc. (Turkey) | |||||||
| Rudolf Storz GmbH (Germany). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| CUTISS AG | Oct-24 | CUTISS AG successfully performed the first U.S.-based grafting procedure of denovoSkin, an autologous bio-engineered skin graft, at Massachusetts General Hospital. Conducted under an FDA single-patient Investigational New Drug application, this milestone represents a strategic advancement in regenerative medicine and demonstrates the clinical feasibility of personalized, bio-engineered tissue therapies for complex reconstructive burn treatment. |
| Medline | Mar-24 | The FDA approved the Medline Autologous Regeneration of Tissue (ART) Skin Harvesting System, a semi-automated handheld device for micrograft application. By utilizing needle-based harvesting rather than traditional blades, the device enables minimally invasive procedures under local anesthesia, expanding the capability for skin regeneration in clinical settings and diversifying the technological options available for wound care. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Skin Grafting Device Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Graft Type Compatibility | Split-Thickness Graft, Full-Thickness Graft, Both Graft Types |
| Procurement Model | Capital Equipment Purchase, Rental/Leasing, Procedure-Based Procurement |
| Degree of Automation | Manual Devices, Semi-Automated Devices, Fully Automated Devices |
Skin Grafting Device Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Reconstructive Surgery Procedure Opportunity Assessment |
|
| Burn Care Center Procurement Benchmark |
|
| Reimbursement and Market Access Evaluation |
|
Need a different cut of the data?
Request Custom ResearchHow big is the skin grafting device market?
What is the anticipated CAGR of the skin grafting device industry?
How is rising incidence of severe burn injuries influencing demand for advanced skin grafting devices?
How are reimbursement frameworks affecting adoption of skin grafting technologies?
Why do dermatomes dominate the skin grafting device market?
What is driving growth in chronic wound care within the skin grafting device market?
Why does North America lead the skin grafting device market?
What is driving skin grafting device market growth in Asia Pacific?
Who are the major participants shaping the skin grafting device landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization